0 人已收藏
17 人已预约
上 | 预约 | |||||||||||||||
下 | ||||||||||||||||
晚 |
如需在特定时间就诊, 查看科室值班 预约同科室的其它医生
1. Yang F, Qin Y, Lv J, et al. Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death Dis. 2018 Sep 24;9(10):1000. (通讯作者)
2. Yang F, Li A , Qin Y, et al. A Novel Circular RNA Mediates Pyroptosis of Diabetic Cardiomyopathy by Functioning as a Competing Endogenous RNA. Mol Ther Nucleic Acids. 2019 Jul17;17:636-643. (通讯作者)
3. Che H, Wang Y, Li H, Li Y, Sahil A, Lv J, Liu Y, Yang Z, Dong R, Xue H, Wang L. Melatonin alleviates cardiac fibrosis via inhibiting lncRNA MALAT1/miR-141-mediated NLRP3 inflammasome and TGF-β1/Smads signaling in diabetic cardiomyopathy. FASEB J. 2020 Feb 17. doi: 10.1096/fj.201902692R. (通讯作者)
4. Yang F, Qin Y, Wang Y, et al. LncRNA KCNQ1OT1 Mediates Pyroptosis in Diabetic Cardiomyopathy. Cell Physiol Biochem. 2018;50(4):1230-1244. (通讯作者)
5. Zhou T, Meng X, Che H, et al. Regulation of insulin resistance by multiple miRNAs via targeting the GLUT4 signalling pathway. Cell Physiol Biochem. 2016;38(5):2063-78. (通讯作者)
6. Che H, Wang Y, Li Y et al. Inhibition of microRNA-150-5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts. J Cell Physiol. 2019 Nov 11.(通讯作者)
7. Yang F, Qin Y, Wang Y, et al. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy. Int J Biol Sci 2019;15:1010-1019.DOI:10.7150/ijbs.29680. (通讯作者)
8. Wang Y, Li H, Li Y, et al. Coriolus versicolor alleviates diabetic cardiomyopathy by inhibiting cardiac fibrosis and NLRP3 inflammasome activation. Phytother Res 2019.DOI:10.1002/ptr.6448.(通 讯作者)
9. Xian HM, Che H, Qin Y,et al. Coriolus versicolor aqueous extract ameliorates insulin resistance with PI3K/Akt and p38 MAPK signaling pathways involved in diabetic skeletal muscle. Phytother Res. 2018 Mar;32(3):551-560. (通讯作者).
10. Shen N, Li X, Zhou T, Bilal MU, et al. Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling. J Ethnopharmacol. 2014 Nov 18;157:161-70. (通讯作 者)
11. Sheng X, Che H, Ji Q, et al. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease. Horm Metab Res. 2018 May;50(5):397-402. (通讯作者)
12. Li Q, Li Z, Lin Y et al. High glucose promotes hepatic fibrosis via miR-32/MTA3 mediated Epithelial-to-Mesenchymal Transition. Molecular Medicine Reports. (通讯作者)
13. Meng S, Yang F, Wang Y, Qin Y, Xian H, Che H, Wang L. Silymarin ameliorates diabetic cardiomyopathy via inhibiting TGF-β1/Smad signaling. Cell Biol Int. 2018 Nov 29. doi: 10.1002/cbin.11079. (通讯作者)
14. Fan Yang, Yongting Zhao, Jie Lv, Xia Sheng, Lihong Wang. A new compound heterozygous mutation in a female with 17α-hydroxylase/17,20-lyase deficiency, slipped capital femoral epiphysis and adrenal myelolipoma. Gynecological Endocrinology. (通讯作者)
15. Zhao Y, Yang F, Qiu L et al. A novel heterozygous intron mutation in SEMA7A causing kallmann syndrome in a female. Gynecol Endocrinol. 2019 Oct 25:1-4. (通讯作者)
16. Zhao Y, Yang F , Wang L et al. Familial hypophosphatemic rickets caused by a PHEX gene mutation accompanied by a NPR2 missense mutation. J Pediatr Endocrinol Metab. 2020 Jan 13. (通讯 作者)
17. Wang LH, Li XL, Li Q, Fu Y, et al. Berberine alleviates ischemic arrhythmias via recovering depressed Ito and Ica currents in diabetic rats. Phytomedicine. 2012 Feb 15;19(3-4):206-10. (第一作 者)
18. Wang LH, Yu CH, Fu Y, Li Q, Sun YQ. Berberine elicits anti-arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model. Phytother Res. 2011 Jan;25(1):33-7. doi: 10.1002/ptr.3097. (第一作者)
19. Ai J, Wang LH, Zhang R, et al. Protective effect of the daming capsule on impaired baroreflexes in STZ-induced diabetic rats with hyperlipoidemia. BMC Complement Altern Med. 2010 Dec 22;10:80. (第一作者)
20. Ai J, Zhang R, Li Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun. 2010 Jan 1;391(1):73-7.擅长:内分泌代谢疾病
擅长:擅长治疗糖尿病、甲状腺功能亢进症、甲状腺功能减退症、肾上腺疾病、下丘脑-垂体疾病、骨质疏松症、痛风等各种内分泌疾病,尤其擅长治疗妊娠糖尿病及妊娠甲状腺疾病。擅长应用胰岛素泵及动态血糖仪对糖尿病病人进行血糖管理治疗。
擅长:长甲状腺、垂体、肾上腺疾病、糖尿病、痛风等各种内分泌代谢性疾病的诊治
擅长:擅长糖尿病及其急慢性并发症、甲状腺疾病(甲亢、甲减、甲状腺结节)、垂体-肾上腺疾病、骨质疏松症、痛风等各种内分泌代谢性疾病的诊治。
擅长:擅长诊治糖尿病、甲状腺疾病、肾上腺疾病等内分泌疾病。
擅长:擅长内分泌内科专业,如:糖尿病及垂体、肾上腺、甲状腺等疾病。
擅长:糖尿病及其急慢性并发症的诊疗,甲状腺疾病,肾上腺疾病,垂体疾病以及矮小症、性发育异常、肥胖症、内分泌相关不孕不育等诊治。
擅长:
擅长:长期从事内分泌科临床工作,积累较丰富的临床诊疗经验。擅长糖尿病及并发症的诊治,肾上腺疾病诊疗、甲状腺疾病、继发性高血压、电解质紊乱等。
擅长:糖尿病及相关并发症,多囊卵巢综合征及其他代谢性疾病。
擅长:擅长糖尿病及其各种并发症、甲状腺疾病(甲状腺功能亢进症、甲状腺功能减退症、甲状腺结节)、痛风、肾上腺疾病、下丘脑-垂体疾病等各种内分泌疾病的诊治,擅长应用胰岛素、胰岛素泵对糖尿病病人进行血糖管理治疗。
擅长: 擅长诊治糖尿病、甲状腺疾病、垂体及肾上腺疾病、肥胖症及骨质疏松等内分泌代谢性疾病。
预约时间:
可提前预约两周的门诊挂号。
预约方式:
预约方式:本网站仅保留更新医生和科室信息,已取消预约功能,如需预约挂号请手机关注“暨南大学附属第一医院”微信公众号或支付宝“广州华侨医院”小程序
【详细】